We have confirmed that the tau preparations used for electrophysiological analysis were oligomeric, bearing the aggregation-defining repeat domain and a clinically relevant mid-region epitope used in biomarker tests for tauopathies (Chen et al., 2019). This evidence concerns the gene MAPT and tauopathy.